Page 40 - Saclay News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Positive opinion from Committee for Medicinal Products for Human Use recommending approval of Bylvay® (odevixibat) based on Phase III ASSERT clinical-trial data in Alagille syndrome (ALGS) already received in July 2023Committee for Orphan Medicinal Products confirms a negative opinion of its review recommending not to maintain the orphan designation for Bylvay in ALGSIpsen plans to submit a new Marketing Authorisation Application for the treatment of ALGS by the end of 2023 under a new brand nam

Science News: Scientists have discovered that horsehair worms possess a wide range of genes that enable them to manipulate their host insects, particularly mantises

Investegate announcements from Ipsen updates on E.U. Marketing Authorisation Application for odevixibat in Alagille syndrome

EconoTimes is a fast growing non-partisan source of news and intelligence on global economy and financial markets, providing timely, relevant, and critical insights for market professionals and those who want to make informed investment decisions.

IBM Research created an alternative to the von Neumann architecture in its new NorthPole AI chip, reportedly resulting in both faster and more energy-efficient edge processing.